Bristol-Myers Squibb (BMY) News Today $51.33 +0.62 (+1.22%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM TrialApril 14 at 5:39 PM | gurufocus.comBristol Myers' heart disease drug fails to meet main goals in late-stage studyApril 14 at 4:24 PM | reuters.comPetros Family Wealth LLC Acquires Shares of 9,555 Bristol-Myers Squibb (NYSE:BMY)Petros Family Wealth LLC bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 9,555 shares of the biopharmaceutical company's stock, valued at approximately $540April 14 at 6:34 AM | marketbeat.comHeritage Trust Co Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)Heritage Trust Co acquired a new position in Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 21,454 shares of the biopharmaceutical company'April 14 at 6:16 AM | marketbeat.comKennedy Capital Management LLC Purchases 21,118 Shares of Bristol-Myers Squibb (NYSE:BMY)Kennedy Capital Management LLC boosted its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 25.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 104,751 shares of theApril 14 at 6:00 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Price Target Cut to $54.00 by Analysts at UBS GroupUBS Group reduced their price target on shares of Bristol-Myers Squibb from $60.00 to $54.00 and set a "neutral" rating for the company in a research report on Friday.April 13 at 11:04 AM | marketbeat.comScotia Capital Inc. Increases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)Scotia Capital Inc. boosted its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 66.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 342,885 shares of the biopharmaceutical company's stock after aApril 13 at 6:27 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Sold by DRW Securities LLCDRW Securities LLC lessened its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 89.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,056 shares of the biopharmaceutical company's stoApril 13 at 6:09 AM | marketbeat.comZuckerman Investment Group LLC Lowers Stake in Bristol-Myers Squibb (NYSE:BMY)Zuckerman Investment Group LLC lowered its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 17.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 42,202 shares of the biopharmaceutical company's stock after selling 9,137 sharesApril 12 at 9:12 AM | marketbeat.comTreasurer of the State of North Carolina Has $59.41 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)Treasurer of the State of North Carolina lessened its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,050,308 shares of the biopharmaceutical companyApril 12 at 8:46 AM | marketbeat.comLSV Asset Management Trims Position in Bristol-Myers Squibb (NYSE:BMY)LSV Asset Management lowered its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 2.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,319,218 shares of the biopharmaceutical company's stock afterApril 12 at 8:05 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by Renaissance Technologies LLCRenaissance Technologies LLC grew its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 16.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,060,533 shares of the biopharmaceutical company's stock afteApril 12 at 6:28 AM | marketbeat.comBank of Nova Scotia Purchases 116,513 Shares of Bristol-Myers Squibb (NYSE:BMY)Bank of Nova Scotia grew its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 25.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 581,750 shares of the biopharmaceutical company's stocApril 12 at 6:24 AM | marketbeat.comRep. Greg Landsman Sells Bristol-Myers Squibb (NYSE:BMY) SharesRepresentative Greg Landsman (D-Ohio) recently sold shares of Bristol-Myers Squibb (NYSE:BMY). In a filing disclosed on April 08th, the Representative disclosed that they had sold between $1,001 and $15,000 in Bristol-Myers Squibb stock on March 27th. The trade occurred in the Representative's "ROCApril 12 at 2:03 AM | marketbeat.comBristol Myers says FDA approves Opdivo plus Yervoy as first-line HCC treatmentApril 12 at 12:00 AM | markets.businessinsider.comIs Bristol-Myers Squibb Company (BMY) One of the Best Medical Stocks to Buy According to Billionaires?April 11 at 6:59 PM | msn.comApril 11 at 5:40 PM | gurufocus.comBristol-Myers Squibb Co (BMY) Gains FDA Approval for Opdivo and Yervoy in Liver Cancer ...April 11 at 5:40 PM | gurufocus.comU.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular CarcinomaApril 11 at 3:49 PM | businesswire.comHere's What to Expect From Bristol-Myers Squibb's Next Earnings ReportApril 11 at 1:41 PM | msn.comThis Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working.April 11 at 8:28 AM | barrons.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by APG Asset Management US Inc.APG Asset Management US Inc. lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 42.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,897 shares ofApril 11 at 7:28 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by Martingale Asset Management L PMartingale Asset Management L P raised its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 119.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 505,139 shares of the biopharmaceutical cApril 11 at 6:54 AM | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Bought by Advisory Services Network LLCAdvisory Services Network LLC lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 15.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 101,250 shares of the biopharmaceutical company's stock afApril 11 at 6:45 AM | marketbeat.comRathbones Group PLC Sells 5,603 Shares of Bristol-Myers Squibb (NYSE:BMY)Rathbones Group PLC lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 15.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 31,660 shares of the biopharmaceutical company's stock after selling 5,603April 11 at 6:09 AM | marketbeat.comBristol-Myers Squibb's (BMY) "Neutral" Rating Reiterated at The Goldman Sachs GroupApril 11 at 3:41 AM | americanbankingnews.comBristol-Myers Squibb (NYSE:BMY) Shares Unloaded Rep. Greg LandsmanApril 11 at 2:01 AM | americanbankingnews.comBristol-Myers Squibb: Hold Rating Amid Mixed Revenue Projections and Market ChallengesApril 10, 2025 | tipranks.comBristol-Myers Squibb (NYSE:BMY) Receives Neutral Rating from The Goldman Sachs GroupThe Goldman Sachs Group reiterated a "neutral" rating and issued a $55.00 target price (down previously from $67.00) on shares of Bristol-Myers Squibb in a research report on Tuesday.April 10, 2025 | marketbeat.comAPG Asset Management N.V. Has $87.85 Million Stake in Bristol-Myers Squibb (NYSE:BMY)APG Asset Management N.V. raised its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 220.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,608,400 shares of the biopharmaceutical company's stock after buying anApril 10, 2025 | marketbeat.comNeed Dependable Passive Income? 4 Safe Stocks Paying 4%-10% Dividends Are Tariff Discount PricedApril 10, 2025 | 247wallst.comNeed Dependable Passive Income? 4 Safe Stocks Paying 4%-10% Dividends Are Tariff Discount PricedApril 10, 2025 | 247wallst.comAbacus FCF Advisors LLC Buys 81,017 Shares of Bristol-Myers Squibb (NYSE:BMY)Abacus FCF Advisors LLC raised its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 66.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 203,358 shares of the biopharmaceutical company's stock after purchasing an additional 81,017 shareApril 10, 2025 | marketbeat.comShelton Capital Management Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)Shelton Capital Management lifted its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 95.5% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 215,184 shares of the biopharmaceutical company's stock after purchasing an additional 105,101 shApril 10, 2025 | marketbeat.comFIL Ltd Has $288.56 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)FIL Ltd increased its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 27.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,101,883 shares of the biopharmaceutical company's stock after purchasing an additional 1,098April 10, 2025 | marketbeat.comEmployees Retirement System of Texas Has $2.32 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)Employees Retirement System of Texas decreased its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 27.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,042 sharApril 10, 2025 | marketbeat.comBristol-Myers Squibb (NYSE:BMY) Shares Purchased by Cerity Partners LLCCerity Partners LLC grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 902,704 shares of the biopharmaceutical compApril 10, 2025 | marketbeat.comGrantham Mayo Van Otterloo & Co. LLC Sells 206,953 Shares of Bristol-Myers Squibb (NYSE:BMY)Grantham Mayo Van Otterloo & Co. LLC reduced its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 90.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 21,020 shares of the biopharmaceutical company's stockApril 10, 2025 | marketbeat.comAutos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkbackApril 10, 2025 | cnbc.comBristol Myers wins dismissal of proposed Pomalyst class action, Reuters reportsApril 10, 2025 | markets.businessinsider.comMorgan Stanley Remains a Sell on Bristol-Myers Squibb (BMY)April 10, 2025 | markets.businessinsider.comBristol-Myers gets Pomalyst antitrust case dismissedApril 10, 2025 | msn.comBristol-Myers Squibb Company (BMY): Among the High Growth Dividend Paying Stocks to Invest inApril 10, 2025 | msn.comBristol-Myers Squibb (NYSE:BMY) Achieves Early FDA Approval for Opdivo Plus Yervoy TherapyApril 10, 2025 | finance.yahoo.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'April 9, 2025 | cnbc.comHealthcare Stocks Aren't a Shelter From the Tariff StormApril 9, 2025 | barrons.comHealthcare Stocks Aren't a Shelter From the Tariff StormApril 9, 2025 | barrons.comPharma Stocks Slide Further After Trump Reiterates Tariff Threats on DrugsApril 9, 2025 | wsj.comPharmaceutical stocks fall as Trump doubles down on tariffs threatApril 9, 2025 | cnbc.com Remove Ads Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address BMY Media Mentions By Week BMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMY News Sentiment▼1.040.86▲Average Medical News Sentiment BMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMY Articles This Week▼7134▲BMY Articles Average Week Remove Ads Get Bristol-Myers Squibb News Delivered to You Automatically Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Johnson & Johnson News Today AbbVie News Today Merck & Co., Inc. News Today Pfizer News Today Zoetis News Today Royalty Pharma News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BMY) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BMY Stock Free BMY Stock Alerts